Posts by David M. Wu, MD, PhD
-
Gene Therapy Reverses Degeneration of the Retinal Pigment Epithelium in Preclinical Models
Gene therapy with Nrf2—a master transcription factor—preserves the retinal pigment epithelium in mouse models of retinitis pigmentosa, David M. Wu, MD, PhD, of the Department of Ophthalmology, and colleagues observed.
Biography
Dr. David Wu is a retina surgeon and researcher at Mass Eye and Ear. His primary practice is located at Mass Eye and Ear, Longwood at 800 Huntington Avenue in Boston. He also sees patients at the main Mass Eye and Ear campus at 243 Charles Street. He treats patients with vitreoretinal diseases, including diabetic retinopathy, macular degeneration, retinal detachments, retinal vascular occlusions, macular holes, epiretinal membranes, and vitreomacular traction. Dr. Wu also is an active participator in the Diabetic Teleretinal Screening Program at Mass Eye and Ear.
Dr. Wu was a member of the selective Inteflex BS/MD program at the University of Michigan (UM). He earned both an MD with distinction in research and a PhD in Neuroscience. After medical school, he completed his ophthalmology residency at the UM W.K. Kellogg Eye Center where he won the George Slocum and James M. LaBerge awards for research as well as the Walter R. Parker teaching award. After residency, he was named a Heed Fellow and completed a Medical Retinal and Research fellowship at UM. Next, he completed subspecialty training in vitreoretinal surgery at the Doheny Eye Institute, Keck School of Medicine at the University of South California where he won an Excellence in Teaching award. He joined the faculty at Mass Eye and Ear in July 2012.
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
